MSD extends immuno-oncology collaboration with Agenus
3 June 2015 | By Victoria White
MSD has extended its existing collaborative research agreement with Agenus for the discovery and development of therapeutic antibodies...
List view / Grid view
News
Auspherix raises £6 million to progress novel antibiotics and establishes UK operations
3 June 2015 | By Victoria White
Auspherix has raised £6 million in a Series A venture financing and is establishing operations on the Stevenage Bioscience Catalyst site...
Anti-Ebola MVA vaccine produced on ProBioGen’s AGE1.CR cell line platform enters clinical trials
3 June 2015 | By Victoria White
An investigational vaccine against Ebola, produced on ProBioGen’s proprietary, continuous muscovy duck AGE1.CR cell line, has proceeded into clinical trials...
LDC and Qurient sign licence agreement to advance CDK7 inhibitors for the treatment of cancer
3 June 2015 | By Victoria White
LDC and Qurient have signed a licence deal providing Qurient with exclusive worldwide rights to a series of highly-selective CDK7 inhibitors...
Astellas and Anokion establish Kanyos Bio to develop products for type 1 diabetes and coeliac disease
2 June 2015 | By Victoria White
Astellas Pharma and Anokion are to collaborate in the fields of type 1 diabetes and coeliac disease by establishing new drug discovery company Kanyos Bio...
MGB Biopharma succeeds in developing an IV formulation of MGB-BP-3 for the treatment of hospital-acquired infections
2 June 2015 | By Victoria White
MGB Biopharma has developed a stable IV formulation of MGB-BP-3 for the treatment of Gram-positive hospital-acquired infections...
Genticel announces positive preclinical proof of concept results for its multivalent HPV therapeutic vaccine GTL002
2 June 2015 | By
Genticel has announced positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate...
Researchers engineer probiotics to detect liver tumours
1 June 2015 | By Victoria White
Engineers at MIT and the University of California at San Diego (UCSD) have devised a way to detect liver tumours, by enlisting the help of probiotics...
Analysis of human aqueous humour reveals 386 new proteins as biomarker candidates
1 June 2015 | By Victoria White
Researchers analysing human aqueous humour samples have identified 763 proteins – including 386 proteins detected for the first time...
AZ and Lilly team up to evaluate MEDI4736 and ramucirumab in advanced solid tumours
1 June 2015 | By Victoria White
AstraZeneca and Lilly have entered into a clinical trial collaboration to evaluate MEDI4736 in combination with ramucirumab in advanced solid tumours...
Padlock Therapeutics accelerates pipeline development through agreement with GSK
29 May 2015 | By Victoria White
Padlock Therapeutics has entered into an agreement to license intellectual property and a collection of assets targeted at PADs from GSK...
First subject dosed in Phase 1 clinical trial of EMB-001
29 May 2015 | By Victoria White
Embera NeuroTherapeutics has announced that the first subject has received the initial dose in a Phase 1 clinical trial evaluating EMB-001...
Presence of IGFBPs correlates with tumour-promoting effects of MMP9 in breast cancer
29 May 2015 | By Victoria White
A team of researchers has found that the presence of IGFBP-1 interacted with MMP9 to promote breast cancer tumour formation in mouse models...
Degenerating white matter may be early marker of Alzheimer’s disease
29 May 2015 | By Victoria White
Degeneration of the white matter of the brain may be an early marker of specific types of Alzheimer's disease, including early-onset Alzheimer's disease...
TSRI scientists win $2.2 million to expand study of IP6K1 to help develop new obesity therapies
28 May 2015 | By Victoria White
TSRI scientists have been awarded nearly $2.2 million to advance understanding of IP6K1 and develop innovative approaches for the treatment of obesity...
